TY - JOUR
T1 - Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade
AU - Kaur, Gurman
AU - Porter, Caroline B.M.
AU - Ashenberg, Orr
AU - Lee, Jack
AU - Riesenfeld, Samantha J.
AU - Hofree, Matan
AU - Aggelakopoulou, Maria
AU - Subramanian, Ayshwarya
AU - Kuttikkatte, Subita Balaram
AU - Attfield, Kathrine E.
AU - Desel, Christiane A.E.
AU - Davies, Jessica L.
AU - Evans, Hayley G.
AU - Avraham-Davidi, Inbal
AU - Nguyen, Lan T.
AU - Dionne, Danielle A.
AU - Neumann, Anna E.
AU - Jensen, Lise Torp
AU - Barber, Thomas R.
AU - Soilleux, Elizabeth
AU - Carrington, Mary
AU - McVean, Gil
AU - Rozenblatt-Rosen, Orit
AU - Regev, Aviv
AU - Fugger, Lars
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Fetal growth restriction (FGR) affects 5–10% of pregnancies, and can have serious consequences for both mother and child. Prevention and treatment are limited because FGR pathogenesis is poorly understood. Genetic studies implicate KIR and HLA genes in FGR, however, linkage disequilibrium, genetic influence from both parents, and challenges with investigating human pregnancies make the risk alleles and their functional effects difficult to map. Here, we demonstrate that the interaction between the maternal KIR2DL1, expressed on uterine natural killer (NK) cells, and the paternally inherited HLA-C*0501, expressed on fetal trophoblast cells, leads to FGR in a humanized mouse model. We show that the KIR2DL1 and C*0501 interaction leads to pathogenic uterine arterial remodeling and modulation of uterine NK cell function. This initial effect cascades to altered transcriptional expression and intercellular communication at the maternal-fetal interface. These findings provide mechanistic insight into specific FGR risk alleles, and provide avenues of prevention and treatment.
AB - Fetal growth restriction (FGR) affects 5–10% of pregnancies, and can have serious consequences for both mother and child. Prevention and treatment are limited because FGR pathogenesis is poorly understood. Genetic studies implicate KIR and HLA genes in FGR, however, linkage disequilibrium, genetic influence from both parents, and challenges with investigating human pregnancies make the risk alleles and their functional effects difficult to map. Here, we demonstrate that the interaction between the maternal KIR2DL1, expressed on uterine natural killer (NK) cells, and the paternally inherited HLA-C*0501, expressed on fetal trophoblast cells, leads to FGR in a humanized mouse model. We show that the KIR2DL1 and C*0501 interaction leads to pathogenic uterine arterial remodeling and modulation of uterine NK cell function. This initial effect cascades to altered transcriptional expression and intercellular communication at the maternal-fetal interface. These findings provide mechanistic insight into specific FGR risk alleles, and provide avenues of prevention and treatment.
UR - http://www.scopus.com/inward/record.url?scp=85135171777&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-32171-w
DO - 10.1038/s41467-022-32171-w
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35906236
AN - SCOPUS:85135171777
SN - 2041-1723
VL - 13
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 4398
ER -